• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬化素是动脉僵硬度的一个潜在候选标志物:来自卡塔尼亚一项队列研究的结果。

Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania.

作者信息

Gaudio Agostino, Fiore Valerio, Rapisarda Rosario, Sidoti Maria Helga, Xourafa Anastasia, Catalano Antonino, Tringali Giovanni, Zanoli Luca, Signorelli Salvatore Santo, Fiore Carmelo Erio

机构信息

Department of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy.

Department of Clinical and Experimental Medicine, University of Messina, I-98125 Messina, Italy.

出版信息

Mol Med Rep. 2017 May;15(5):3420-3424. doi: 10.3892/mmr.2017.6390. Epub 2017 Mar 24.

DOI:10.3892/mmr.2017.6390
PMID:28339088
Abstract

Osteoporosis and cardiovascular disease are worldwide public health issues. Recent evidence indicates a possible role of the canonical Wnt/β-catenin signalling pathway as a common mediator between these two diseases. The aim of the present study was to investigate the relationship between serum concentrations of sclerostin and Dkk1, two extracellular inhibitors of Wnt/β-catenin signalling, with carotid intima-media thickness (CIMT) and with arterial stiffness, evaluated by measuring the pulse wave velocity (PWV) in an ambulatory population of adults. To this aim, 67 subjects were recruited in the 'Atherosclerosis and osteoporosis: identification of common pathogenetic factors' investigation. Serum sclerostin levels correlated positively with CIMT (r=0.314, p=0.03) and inversely with the augmentation index, a marker of arterial stiffness (r=-0.286, p<0.05), whereas Dkk1 did not. Moreover, in a multivariate linear regression model, sclerostin [β -0.1472; p=0.0023; standard error (SE)=0.04620] was an independent predictor of PWV in the study subjects. Our study shows that, following adjustment for confounders, sclerostin is an independent predictor of arterial stiffness in an ambulatory population, whereas Dkk1 is not.

摘要

骨质疏松症和心血管疾病是全球性的公共卫生问题。最近的证据表明,经典的Wnt/β-连环蛋白信号通路可能是这两种疾病之间的共同介导因素。本研究的目的是调查硬化素和Dkk1(Wnt/β-连环蛋白信号的两种细胞外抑制剂)的血清浓度与颈动脉内膜中层厚度(CIMT)以及与动脉僵硬度之间的关系,动脉僵硬度通过测量成年门诊人群的脉搏波速度(PWV)进行评估。为此,在“动脉粥样硬化与骨质疏松症:共同致病因素的识别”调查中招募了67名受试者。血清硬化素水平与CIMT呈正相关(r = 0.314,p = 0.03),与作为动脉僵硬度标志物的增强指数呈负相关(r = -0.286,p < 0.05),而Dkk1则不然。此外,在多变量线性回归模型中,硬化素[β -0.1472;p = 0.0023;标准误差(SE)= 0.04620]是研究对象中PWV的独立预测因子。我们的研究表明,在对混杂因素进行校正后,硬化素是门诊人群动脉僵硬度的独立预测因子,而Dkk1则不是。

相似文献

1
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania.硬化素是动脉僵硬度的一个潜在候选标志物:来自卡塔尼亚一项队列研究的结果。
Mol Med Rep. 2017 May;15(5):3420-3424. doi: 10.3892/mmr.2017.6390. Epub 2017 Mar 24.
2
The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.绝经后妇女中 Wnt 信号通路抑制剂(Dickkopf-1(DKK1)和骨硬化蛋白)、骨密度、血管钙化和动脉僵硬度之间的关系。
Bone. 2013 Sep;56(1):42-7. doi: 10.1016/j.bone.2013.05.010. Epub 2013 May 20.
3
The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.绝经后 2 型糖尿病女性中 Wnt 信号通路抑制剂(骨硬化蛋白和 Dickkopf-1)与颈动脉内膜中层厚度的关系。
Diab Vasc Dis Res. 2014 Jan;11(1):48-52. doi: 10.1177/1479164113510923. Epub 2013 Nov 12.
4
Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.2型糖尿病患者中骨硬化蛋白和Dickkopf-1与主动脉僵硬度的相关性:一项前瞻性横断面研究。
Diab Vasc Dis Res. 2019 May;16(3):281-288. doi: 10.1177/1479164118816661. Epub 2018 Dec 14.
5
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.血清硬化蛋白水平作为高血压患者中心动脉僵硬度的潜在生物标志物。
BMC Cardiovasc Disord. 2018 Nov 27;18(1):214. doi: 10.1186/s12872-018-0955-5.
6
Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.血清硬化蛋白作为肾移植受者外周动脉僵硬度的独立标志物:一项横断面研究。
Medicine (Baltimore). 2016 Apr;95(15):e3300. doi: 10.1097/MD.0000000000003300.
7
Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.透析前慢性肾脏病(CKD)患者循环中的骨硬化蛋白和 Dickkopf-1(DKK1):与骨密度和动脉僵硬度的关系。
Calcif Tissue Int. 2012 Jun;90(6):473-80. doi: 10.1007/s00223-012-9595-4. Epub 2012 Apr 21.
8
Relationship between carotid intima-media thickness and carotid artery stiffness assessed by ultrafast ultrasound imaging in patients with type 2 diabetes.2 型糖尿病患者应用超快超声成像技术评估颈动脉内中膜厚度与颈动脉僵硬度的关系。
Eur J Radiol. 2019 Feb;111:34-40. doi: 10.1016/j.ejrad.2018.12.016. Epub 2018 Dec 14.
9
Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.血清硬化蛋白水平可能是普通血液透析患者动脉僵硬度的潜在生物标志物。
Biomark Med. 2016 Jul;10(7):689-99. doi: 10.2217/bmm-2016-0031. Epub 2016 Jun 27.
10
Wnt/β-catenin pathway inhibitors, bone metabolism and vascular health in kidney transplant patients.Wnt/β-catenin 通路抑制剂、肾移植患者的骨代谢和血管健康。
J Nephrol. 2023 May;36(4):969-978. doi: 10.1007/s40620-022-01563-y. Epub 2023 Jan 30.

引用本文的文献

1
Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study.探索血小板计数、全身免疫炎症指数与绝经后骨质疏松症女性骨折风险之间的关联:一项横断面研究。
J Clin Med. 2025 Aug 2;14(15):5453. doi: 10.3390/jcm14155453.
2
Role of Sclerostin in Cardiovascular System.硬化蛋白在心血管系统中的作用。
Int J Mol Sci. 2025 May 9;26(10):4552. doi: 10.3390/ijms26104552.
3
Anticipation for hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma.
肝动脉灌注化疗在肝细胞癌治疗中的应用前景。
World J Gastrointest Oncol. 2025 Feb 15;17(2):100505. doi: 10.4251/wjgo.v17.i2.100505.
4
Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus.骨硬化蛋白作为系统性红斑狼疮女性心血管风险的生物标志物。
Sci Rep. 2022 Dec 14;12(1):21621. doi: 10.1038/s41598-022-25651-y.
5
Arterial Stiffness and the Canonical WNT/β-catenin Pathway.动脉僵硬度与经典 WNT/β-连环蛋白通路。
Curr Hypertens Rep. 2022 Nov;24(11):499-507. doi: 10.1007/s11906-022-01211-7. Epub 2022 Jun 21.
6
Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.血脂异常患者的骨骼健康:一个被低估的方面。
Int J Mol Sci. 2022 Jan 31;23(3):1639. doi: 10.3390/ijms23031639.
7
Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension.血清硬化蛋白与原发性高血压患儿的外周和中心收缩压相关。
J Clin Med. 2021 Aug 13;10(16):3574. doi: 10.3390/jcm10163574.
8
Narrative Review of Carotid disease and the kidney.颈动脉疾病与肾脏的叙述性综述
Ann Transl Med. 2021 Jul;9(14):1210. doi: 10.21037/atm-20-5001.
9
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up.硬化素水平对接受冠状动脉造影患者长期预后的影响:一项为期9年随访的个性化研究
J Pers Med. 2021 Mar 6;11(3):186. doi: 10.3390/jpm11030186.
10
Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis.骨脆弱机制:从成骨不全症到继发性骨质疏松症。
Int J Mol Sci. 2021 Jan 10;22(2):625. doi: 10.3390/ijms22020625.